{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:17:38Z","timestamp":1790637458491,"version":"4.1.0"},"reference-count":21,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,7,8]],"date-time":"2008-07-08T00:00:00Z","timestamp":1215475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:p>\n                    <jats:bold>Objectives.\u2014<\/jats:bold>\n                    This study seeks to determine whether menstrual\u2010related migraine (MRM) has a discrete, attributable impact on migraine chronicity and medication overuse.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Background.\u2014<\/jats:bold>\n                    Menstrual\u2010related migraine can be a disabling headache on its own; but when seen in headache clinics, it is often enmeshed in the setting of chronic migraine (CM) and medication overuse headache (MOH). Whereas nonspecific migraine preventives bestow their benefit uniformly, hormonal preventives (HPs)\u2014when they are successful\u2014address a discrete hormonal mechanism. They confer no known benefit to migraines that are not hormonally triggered. This selective property of HPs could potentially isolate MRM and segregate its effect on the overall clinical picture.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.\u2014<\/jats:bold>\n                    This is a retrospective review of 229 consecutive women seen in follow\u2010up for hormonal prevention of MRM at an academic headache center. Patients kept standardized diaries from which separate menstrual\u2010week (MW) and non\u2010menstrual week (nonMW) headache indices were calculated and compared. Resolution of MRM was defined by reduction of the MW headache index to a score not exceeding the nonMW headache indices. Consumption of all acute and preventive agents used in the preceding month was tallied. We performed post\u2010treatment comparisons of medication usage and headache characteristics among subjects in whom MRM was resolved and those in whom it was not resolved.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.\u2014<\/jats:bold>\n                    At baseline, CM was present in 92% of subjects, 72% of whom also met criteria for MOH. Resolution of MRM was achieved in 81% of subjects who were compliant with HP and was associated with reversion to episodic migraine (59% vs 18%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u2003.001) and resolution of medication overuse (54% vs 20%,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u2003.001). Resolution of MRM was associated with significant decreases in per capita consumption of triptans, opioids, all acute agents, and migraine preventive medications.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions.\u2014<\/jats:bold>\n                    Resolution of MRM correlated not only with conversion of CM to an episodic pattern, but also with a significant reduction in medication usage. It offers preliminary evidence that hormonal regimens may have a beneficial role in prevention of MRM.\n                  <\/jats:p>","DOI":"10.1111\/j.1526-4610.2008.01176.x","type":"journal-article","created":{"date-parts":[[2008,7,8]],"date-time":"2008-07-08T12:21:34Z","timestamp":1215519694000},"page":"1186-1193","source":"Crossref","is-referenced-by-count":46,"title":["Elimination of Menstrual\u2010Related Migraine Beneficially Impacts Chronification and Medication Overuse"],"prefix":"10.1111","volume":"48","author":[{"given":"Anne","family":"Calhoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutapa","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,2]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1468-2982.1996.1601011.x","article-title":"Menstrual\u201d migraine: Towards a definition","volume":"16","author":"MacGregor EA.","year":"1996","journal-title":"Cephalalgia"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1468-2982.2004.00741.x","article-title":"Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres","volume":"24","author":"Granella F","year":"2004","journal-title":"Cephalalgia"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/01.WNL.0000133134.68143.2E","article-title":"Prevalence of migraine on each day of the natural menstrual cycle","volume":"63","author":"MacGregor EA","year":"2004","journal-title":"Neurology"},{"key":"e_1_2_7_5_2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1526-4610.2004.04127.x","article-title":"Disability in chronic migraine patients with medication overuse: Treatment effects at 1\u2010year follow\u2010up","volume":"44","author":"Grazzi L","year":"2004","journal-title":"Headache"},{"key":"e_1_2_7_6_2","first-page":"1","article-title":"The international classification of headache disorders","volume":"24","author":"Headache Classification Committee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1212\/WNL.22.4.355","article-title":"The role of estradiol withdrawal in the etiology of menstrual migraine","volume":"22","author":"Somerville BW.","year":"1972","journal-title":"Neurology"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1212\/01.wnl.0000233888.18228.19","article-title":"Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen","volume":"67","author":"MacGregor EA","year":"2006","journal-title":"Neurology"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.46.11.1044","article-title":"Treatment of menstrual migraine by oestradiol implants","volume":"46","author":"Magos AL","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0015-0282(97)81928-0","article-title":"Effective treatment of severe menstrual migraine headaches with gonadotropin\u2010releasing hormone agonist and \u201cadd\u2010back\u201d therapy","volume":"67","author":"Murray SC","year":"1997","journal-title":"Fertil Steril"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/09513598809023619","article-title":"Menstrual migraine: A double\u2010blind trial of percutaneous estradiol","volume":"2","author":"Dennerstein L","year":"1988","journal-title":"Gynecol Endocrinol"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1136\/bmj.293.6561.1540","article-title":"Prevention of menstrual migraine by percutaneous oestradiol","volume":"293","author":"De Lignieres B","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"e_1_2_7_13_2","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","article-title":"Prevention of menstrual attacks of migraine: A double\u2010blind placebo\u2010controlled crossover study","volume":"67","author":"MacGregor EA","year":"2006","journal-title":"Neurology"},{"key":"e_1_2_7_14_2","first-page":"129","volume-title":"New Advances in Headache Research","author":"Predalier AVD","year":"1994"},{"key":"e_1_2_7_15_2","first-page":"38","article-title":"Four hypotheses for understanding menstrual migraine","volume":"29","author":"Calhoun A.","year":"2004","journal-title":"Female Patient"},{"key":"e_1_2_7_16_2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1526-4610.2003.03092.x","article-title":"Migraine prevalence during menopausal transition","volume":"43","author":"Wang SJ","year":"2003","journal-title":"Headache"},{"key":"e_1_2_7_17_2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1526-4610.2003.03065.x","article-title":"Medical oophorectomy with and without estrogen add\u2010back therapy in the prevention of migraine headache","volume":"43","author":"Martin V","year":"2003","journal-title":"Headache"},{"key":"e_1_2_7_18_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1526-4610.2004.04020.x","article-title":"Migraine and menopause","volume":"44","author":"Calhoun AH.","year":"2004","journal-title":"Headache"},{"key":"e_1_2_7_19_2","first-page":"7","article-title":"Practice guidelines for OC selection: Update","volume":"5","author":"Mishell D","year":"1997","journal-title":"Dialogues Contracept"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.SMJ.0000129924.15619.D9","article-title":"A novel specific prophylaxis for menstrual\u2010associated migraine","volume":"97","author":"Calhoun AH.","year":"2004","journal-title":"South Med J"},{"key":"e_1_2_7_21_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","article-title":"Headaches and oral contraceptives: Impact of eliminating the standard 7\u2010day placebo interval","volume":"47","author":"Sulak P","year":"2007","journal-title":"Headache"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1526-4610.2007.00901.x","article-title":"The mystery of figure 2\u201d\u2014A case for ovulatory migraine?","volume":"47","author":"Calhoun AH.","year":"2007","journal-title":"Headache"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-4610.2008.01176.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-4610.2008.01176.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:03:08Z","timestamp":1762084988000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-4610.2008.01176.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1526-4610.2008.01176.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4610.2008.01176.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}